11月28日，红星新闻从市场监管总局获悉，11月27日，市场监管总局召开2025年第五次企业公平竞争座 谈会，围绕"促进公平竞争，优化营商环境"主题，与三星、宝马、强生、拜耳、正大、宝洁、宜家等外 资企业深入交流，听取意见建议。总局党组成员、副局长孟扬出席会议并讲话。 孟扬介绍了市场监管总局强化反垄断监管执法、深化竞争领域制度型开放、加强公平竞争治理等方面的 工作情况。他强调，总局认真贯彻落实党的二十届四中全会精神，将进一步加强重点领域反垄断执法， 加强公平竞争审查和经营者集中审查，坚决破除阻碍全国统一大市场建设的卡点堵点，营造市场化、法 治化、国际化一流营商环境，充分激发各类经营主体发展活力。 ▲图据图虫创意 红星新闻首席记者 吴阳 ...

Core Viewpoint - Dividend stocks are valuable for providing regular cash flow and can be beneficial for both new and seasoned investors [1] Group 1: Johnson & Johnson - Johnson & Johnson has increased its dividend for 63 consecutive years, classifying it as a Dividend King with a yield of approximately 2.6% [3] - The company holds a "AAA" credit rating from S&P Global, indicating strong financial stability, which allows for significant investments in research and development [4] - Recent acquisitions include Halda Therapeutics for $3.05 billion to enhance its oncology pipeline, Intra-Cellular Therapies for $14.6 billion to expand its neuroscience portfolio, and Shockwave Medical for $13.1 billion to improve its medical device offerings [5][6] - In Q3, Johnson & Johnson reported net sales of $24 billion, a 6.8% year-over-year increase, and net income rose 91% to $5.2 billion [9] Group 2: Coca-Cola - Coca-Cola has also increased its dividend for 63 consecutive years, making it a Dividend King with a yield of about 2.8% [10] - The company employs an asset-light franchise model, focusing on concentrate production and brand strategy while independent bottling partners handle manufacturing and distribution [11] - Coca-Cola's diverse portfolio includes water, juices, coffee, tea, and energy drinks, allowing it to adapt to changing consumer preferences [13] - In Q3 2025, Coca-Cola reported net revenue of $12.5 billion, a 5% increase, and earnings per share of $0.86, reflecting a 30% rise [15] Group 3: Realty Income - Realty Income has paid and raised its dividend for over 30 years, with a current yield of approximately 5.7% and a history of 665 consecutive monthly dividends [16] - The company utilizes a triple-net lease structure, which minimizes exposure to rising operating expenses and provides stable rental income [17] - Realty Income owns over 15,500 properties leased to around 1,650 clients across 92 industries, focusing on service-oriented retail tenants to insulate cash flows [19] - For Q3 2025, Realty Income reported net income of $315.8 million and funds from operations of $981.1 million, representing increases of 21% and 15% year-over-year, respectively [20]

Core Insights - Dividend stocks are attractive for long-term investors seeking reliable cash flow, especially for retirees needing passive income [1][2] - Reinvested dividends can significantly enhance total returns and provide stability during market downturns [2] - The article highlights four top dividend stocks for investment over the next five years [3] Company Summaries Pfizer - Pfizer has maintained 348 consecutive quarterly dividend payments and increased payouts for 16 years, offering a forward yield of around 7% [4][5] - The company is targeting over $7 billion in savings by 2027 to improve operating margins and free cash flow, ensuring it can cover dividend payments while reinvesting [5] - Pfizer reported $9.4 billion in net income on $45 billion in revenue for the first nine months of 2025, with net income up 24% year-over-year [9] Johnson & Johnson - Johnson & Johnson has increased its dividends for 63 consecutive years, yielding around 2.6%, which is more than double the S&P 500 average [10] - The company has a strong balance sheet with an AAA credit rating and over $20 billion in annual free cash flow, supporting continued dividend payouts [10] - In Q3 2025, sales grew by approximately 7% to $24 billion, with adjusted EPS increasing by 16% year-over-year [13] Home Depot - Home Depot has increased its dividend annually for 16 years, currently yielding 2.7% [15] - The company’s recent $5.5 billion acquisition of GMS is expected to enhance its specialty building products business [16] - In Q3, Home Depot's sales rose 2.8% year-over-year to $41.4 billion, with net earnings totaling $3.6 billion [18] Realty Income - Realty Income has a flawless record of paying monthly dividends, with a current yield of approximately 5.7% [20] - The company’s properties are primarily single-tenant, freestanding commercial properties, with over 90% of rental income from resilient businesses [21] - Realty Income's Q3 revenue was $1.47 billion, up about 11% year-over-year, with a strong occupancy rate of 98.7% [23][24]

2025年11月26日， 强生医疗科技（Johnson & Johnson MedTech）美国骨科公司总裁 莱斯利·斯托姆斯（Leslie Storms） 宣布将于本月正式离任， 结束在公司长达18 年的职业生涯。 斯托姆斯在个人LinkedIn主页上发布告别信，感谢团队、公司及其所服务的患者群体。她写道："我非常幸运能与杰出的领导者和才华横溢的团队共事，他们对工作 充满热情，因为他们始终以患者为中心。能在一家帮助我成长、鼓励我以不同视角思考、并在各个方面给予我支持的公司工作，是一段珍贵的经历。"她同时表示， 自己"已准备迎接职业生涯的新篇章"。 此次离任正值强生公司内部结构重组的关键时期。随着骨科业务独立化进程推进，管理层的调整也被视为公司新战略布局的一部分。 # 公司战略背景 过去一年，强生集团正加速实施全球业务重组。2025年10月，公司宣布计划分拆旗下骨科业务板块 DePuy Synthes ，将其作为独立公司运营。该决策旨在让集团聚 焦增长更快、利润率更高的核心领域，包括微创外科、心血管介入及创新医疗器械。 强生方面表示，剥离骨科业务有助于提升整体运营效率，增强各业务单元的战略自主性与市场响应速度 ...

Key TakeawaysGold surged to $4,165 an ounce, driven by strong market expectations of a December US interest-rate cut, supported by dovish Federal Reserve signals and the emergence of Kevin Hassett as a top contender for Fed Chair.Johnson & Johnson (JNJ) reached a monumental $500 billion market value, extending an unprecedented 13-day winning streak fueled by investor confidence in its new drug pipeline and recent acquisitions.New Zealand's business confidence saw a significant jump in November, with the ANZ ...

智通财经APP获悉，周三，强生(JNJ.US)市值达到 5000 亿美元。投资者们持续看好该公司应对其主要 治疗银屑病药物销量下滑策略的成效。周三，这家制药及医疗设备制造商的股价上涨了 0.4%，达到 207.56 美元，首次收于 5000 亿美元上方。该股票已连续 13 个交易日上涨，是强生公司有史以来最长的 连涨纪录，11 月份迄今涨幅达 9.9%，有望创下自 2020 年 4 月以来的最佳单月表现。 华尔街对于该公司在其畅销的治疗银屑病药物Stelara专利到期后填补收入缺口的计划愈发感到乐观。强 生公司正寄希望于新的药物和收购行动来补充其产品线，并弥补Stelara销量下滑所带来的损失。 强生公司的优势在于，投资者正逐渐将资金从美国股市的高风险领域转向更具防御性的板块，同时远离 那些价格高昂的人工智能股票。本月，标普500指数中的医疗保健板块上涨了 9.7%，这将是自 2020 年 4 月以来该板块的最大单月涨幅;而标普500指数中的制药板块在 11 月迄今也上涨了约 17%，有望创下 有史以来的最佳单月表现。 Explosive Options首席期权分析师Bob Lang表示："过去三周半的时间里 ...

Core Viewpoint - Johnson & Johnson's market capitalization has surpassed the $500 billion mark for the first time [1] Group 1 - The achievement of a market cap exceeding $500 billion signifies a notable milestone for Johnson & Johnson [1]

Johnson & Johnson’s stock market valuation is flirting with $500 billion as investors raise their bets that firm’s strategy to cope with eroding sales for its major psoriasis drug will pan out https://t.co/NCRuSaWWuh ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? The ...

Key Takeaways JNJ shares are up 16.7% in three months as momentum builds across its key businessesSector recovery and JNJ's plan to boost U.S. manufacturing support optimism around the stock.Pipeline progress and MedTech improvements underpin expectations for stronger growth ahead.Johnson & Johnson’s (JNJ) stock has risen 16.7% in the past three months. A lot of this price increase is due to strong third-quarter 2025 results, where in both the top and bottom lines exceeded expectations. J&J also raised its ...